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Congestive heart failure (CHF) is an important cause of atrial fibrillation (AF), with structural remodeling, particu-
larly tissue fibrosis, playing a central role.1,2 Fibroblasts are the 
most abundant cells in the heart.3 Fibroblast proliferation and 
differentiation into myofibroblasts are important contributors to 
arrhythmogenesis under conditions like CHF by enhancing the 
production of extracellular matrix proteins, such as collagen, 
and possibly via electric interactions with cardiomyocytes.3
Fibroblasts are known to express a wide range of ion chan-
nels, but their functional role is poorly understood.3 Cardiac fi-
broblasts are not electrically excitable, but they have polarized 
resting membrane potentials (RMPs), with average values as 
negative as −37 mV.4 The primary determinant of fibroblast 
RMP is the inward-rectifier K+ current, IK1.5 We have recently 
shown that voltage-gated (Kv) K+ currents in cardiac fibro-
blasts are remodeled in CHF.6 This study aimed to characterize 
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Rationale: Fibroblasts are involved in cardiac arrhythmogenesis and contribute to the atrial fibrillation substrate 
in congestive heart failure (CHF) by generating tissue fibrosis. Fibroblasts display robust ion currents, but their 
functional importance is poorly understood.
Objective: To characterize atrial fibroblast inward-rectifier K+ current (IK1) remodeling in CHF and its effects on 
fibroblast properties.
Methods and Results: Freshly isolated left atrial fibroblasts were obtained from controls and dogs with CHF 
(ventricular tachypacing). Patch clamp was used to record resting membrane potential (RMP) and IK1. RMP was 
significantly increased by CHF (from −43.2±0.8 mV, control, to −55.5±0.9 mV). CHF upregulated IK1 (eg, at −90 
mV from −1.1±0.2 to −2.7±0.5 pA/pF) and increased the expression of KCNJ2 mRNA (by 52%) and protein (by 
80%). Ba2+ (300 μmol/L) decreased the RMP and suppressed the RMP difference between controls and dogs with 
CHF. Store-operated Ca2+ entry (Fura-2-acetoxymethyl ester) and fibroblast proliferation (flow cytometry) were 
enhanced by CHF. Lentivirus-mediated overexpression of KCNJ2 enhanced IK1 and hyperpolarized fibroblasts. 
Functional KCNJ2 suppression by lentivirus-mediated expression of a dominant negative KCNJ2 construct 
suppressed IK1 and depolarized RMP. Overexpression of KCNJ2 increased Ca2+ entry and fibroblast proliferation, 
whereas the dominant negative KCNJ2 construct had opposite effects. Fibroblast hyperpolarization to mimic 
CHF effects on RMP enhanced the Ca2+ entry. MicroRNA-26a, which targets KCNJ2, was downregulated in CHF 
fibroblasts. Knockdown of endogenous microRNA-26 to mimic CHF effects unregulated IK1.
Conclusions: CHF upregulates fibroblast KCNJ2 expression and currents, thereby hyperpolarizing RMP, increasing 
Ca2+ entry, and enhancing atrial fibroblast proliferation. These effects are likely mediated by microRNA-26a 
downregulation. Remodeling-induced fibroblast KCNJ2 expression changes may play a role in atrial fibrillation 
promoting fibroblast remodeling and structural/arrhythmic consequences.  (Circ Res. 2015;116:836-845. 
DOI: 10.1161/CIRCRESAHA.116.305326.)
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changes in cardiac fibroblast IK1 in CHF and to define underly-
ing mechanisms and potential functional significance.
Methods
Animal Model
Adult mongrel dogs (22–30 kg) were divided into 2 groups: controls 
(28 males and 2 females) and dogs with 2-week ventricular tachypac-
ing–induced congestive heart failure (CHF; 21 males and 3 females). 
Dogs with CHF had unipolar pacing leads inserted fluoroscopically 
into the right ventricular apex, which were programmed at 240 bpm 
for 2 weeks.6 On study days, dogs were anesthetized with morphine (2 
mg/kg subcutaneously) and α-chloralose (120 mg/kg intravenously, fol-
lowed by 29.25 mg/kg per hour) and ventilated mechanically. Effective 
refractory periods were measured at basic cycle lengths of 150, 200, 
250, 300, and 350 ms in the right-atrial appendage, with 10 basic 
stimuli (S1) followed by a premature extrastimulus (S2) with 5-ms 
decrements. AF was induced with atrial burst pacing at 50 Hz and 10 
V. Mean AF duration was based on 10 AF inductions in each dog. If 
the mean duration of the first 5 episodes of AF was >2 minutes, AF 
was induced only 5 times. In 4 dogs per group, tissue sections were 
analyzed for fibrous-tissue content as previously described,2 by an 
investigator blinded to group assignment.
Fibroblast Isolation and Culture
Atrial fibroblasts were obtained from left atria (LA) of adult mongrel 
dogs as previously described.7 Hearts were removed after intra-atrial 
injection of heparin (10 000 U) and immersed in 2 mmol/L of Ca2+-
containing Tyrode solution. The left coronary artery was cannulated, 
and the LA tissue was perfused with 2 mmol/L of Ca2+ Tyrode solution 
(37°C, 100% O2), then with Ca2+-free Tyrode solution (≈10 minutes), 
followed by ≈60-minute perfusion with the same solution contain-
ing collagenase (≈0.48 mg/mL; CLSII, Worthington, OH) and 0.1% 
bovine serum albumin (Sigma). Cells were dispersed by trituration in 
KB (Kraftbruhe) solution (when used for electrophysiological study 
or sample acquisition for mRNA or protein analysis) or Medium 199 
(Invitrogen) supplemented with 10% fetal bovine serum (Gibco), 
penicillin, and streptomycin for culture. Filtration (500-nm nano-
mesh) was used to remove debris, and cells were then centrifuged at 
54.6g for 5 minutes to pellet cardiomyocytes. The supernatant was 
collected and filtered through 50-μm nanomesh and centrifuged at 
314.5g for 10 minutes to concentrate fibroblasts. Freshly isolated fi-
broblasts were then separated; 1 aliquot was flash-frozen in liquid 
N2 and stored for biochemical studies, and the remaining cells were 
cultured on noncoated glass coverslips.7 Fibroblasts were incubated 
in 5% CO2/95% O2 humidified air (37°C). A medium change was 
performed 4 hours after plating to remove any dead cells and debris, 
and the medium was changed every 24 hours.
Ionic Current and RMP Recording
All in vitro recordings were obtained at 37°C. The whole-cell per-
forated–patch technique was used to record RMP in current-clamp 
mode, and tight-seal patch clamp was used to record IK1 in voltage-
clamp mode. Borosilicate glass electrodes filled with pipette solution 
were connected to a patch-clamp amplifier (Axopatch 200A; Axon). 
Electrodes had tip resistances of 6 to 8 MΩ. Nystatin-free intracel-
lular solution was placed in the tip of the pipette by capillary action 
(≈30 s), and then pipettes were backfilled with nystatin-containing 
(600 μg/mL) pipette solution. IK1 was recorded as the 300-μmol/L 
Ba2−–sensitive current. Tyrode solution contained (mmol/L) NaCl 
136, CaCl2 1.8, KCl 5.4, MgCl2 1, NaH2PO4 0.33, dextrose 10, and 
HEPES 5, titrated to pH 7.3 with NaOH. The pipette solution for 
RMP and IK1 recording contained (mmol/L) GTP 0.1, potassium as-
partate 110, KCl 20, MgCl2 1, MgATP 5, HEPES 10, sodium phos-
phocreatine 5, and EGTA 0.005 (pH 7.4, KOH). Junction potentials 
between bath and pipette solutions averaged 10.5 mV and were cor-
rected for RMP measurements only. Currents are expressed as densi-
ties (pA/pF) to control for changes in cell size/capacitance with CHF.
Ca2+ Imaging
One-day cultured canine atrial fibroblasts on microscope cover slips 
were loaded with Fura-2-acetoxymethyl ester (5 μmol/L; Invitrogen) 
in phenol-free M199 medium in the presence of Pluronic F-127 (20% 
solution in dimethylsulfoxide, 2.5 μg/mL) for 30 minutes at 36°C in 
a humidified incubator with 95% air/5% CO2. Cover slips were fixed 
in a perfusion chamber on the stage of a microscope, and fibroblasts 
were superfused with 1.8 mmol/L of Ca2+ Tyrode solution and main-
tained for ≥25 to 30 minutes at room temperature before experimental 
protocols to allow for deesterification of Fura-2-acetoxymethyl ester. 
Fura-2 was excited with dual excitation wavelengths at 340 and 380 
nm, and emission was recorded at a wavelength of 510 nm. Ca2+ im-
aging was obtained with an IonOptix Fluorescence System mounted 
on an upright Nikon FN-1 microscope. To measure store-operated 
Ca2+ entry, cells were first exposed to Ca2+-free solution for 10 min-
utes. [Ca2+]
o
 was then increased to 10 mmol/L to measure Ca2+ entry 
via store-operated channels activated by Ca2+-store depletion.
Cell Proliferation and Cell Cycle Analysis
Cell cycle was analyzed by flow cytometry as previously described.8 
Atrial fibroblasts were seeded at 4000 cells/cm2 in T-25 culture flasks 
(1.0×105 cells per flask; 25 cm2 growth area) and were cultured for 3 
days in M199 medium supplemented with 10% fetal bovine serum. 
The culture medium was replaced with lentivirus-containing medium 
for each group on day 2. Cells were harvested after 48-hour incuba-
tion. After trypsinization, cells were centrifuged at 314.5g for 10 min-
utes and washed in ice-cold PBS, then fixed overnight in 75% ethanol 
and stored at −20°C until assayed. For analysis, stored samples were 
centrifuged at 314.5g for 10 minutes and washed twice in PBS. The 
pelleted samples were resuspended and incubated in propidium io-
dide (Sigma) solution for 20 minutes at 4°C. RNase was added in the 
staining solution to avoid RNA contamination. The stained fibroblast 
population was gated with forward scatter versus side scatter plot to 
display the relationship of cell size versus granularity. Data were ac-
quired using a FACScan flow cytometer (BD Biosciences, San Jose, 
CA), with cell counts obtained during 5 minutes of flow at 60 μL/
min, to create a DNA-content frequency histogram and analyzed with 
Flowjo software (Tree Star Inc). A Dean–Jett–Fox model was then 
used to quantify cell-cycle phases, giving the percentages of cells in 
G0/G1, S, and G2/M. The doublet problem was resolved by a doublet 
discrimination gate.
KCNJ2 Overexpression and Dominant Negative 
Constructs
Lentiviral constructs were used, carrying wild-type or dominant 
negative KCNJ2 cDNAs or pWPI-plasmid negative control express-
ing green fluorescent protein (GFP) only, as previously reported.9 
Lentivirus preparation was performed as previously described.10 LA 
fibroblasts from control dogs were isolated and grown in T75 flasks. 
At near confluence (3–4 days of culture), fibroblasts were trypsinized, 
counted, and plated in 12-well plates at 4.4×104 cells per well. After 4 
to 6 hours of recovery, cells were transduced with lentiviral vectors at 
50 multiplicity of infection. After overnight incubation (≈15 hours), 
cells were washed 3× with 10% fetal bovine serum–containing me-
dium. After an additional 48 hours of culture, electrophysiological 
studies, Ca2+ imaging, or flow cytometry was performed.
Nonstandard Abbreviations and Acronyms
α-SMA α-smooth muscle actin
AF atrial fibrillation
AMO anti-miR oligonucleotide
CHF congestive heart failure
GFP green fluorescent protein
KCNJ2-DN dominant negative KCNJ2 construct
KCNJ2-OE KCNJ2 overexpression
LA left atrial
RMP resting membrane potential
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MicroRNA-26a Knockdown
For overexpression, sense and antisense oligonucleotides were syn-
thesized by Invitrogen, and the double-stranded RNA was created 
by annealing. For knockdown, the anti-miR-26a oligonucleotide 
(AMO-26a) with locked nucleic acid chemistry was synthesized 
by Exiqon. Scrambled oligonucleotides with locked nucleic acid 
were used as negative controls (AMO-NC). LA fibroblasts of dogs 
in primary culture were transfected with AMO-26a (10 nmol/L) or 
AMO-NC (10 nmol/L) with Lipofectamine 2000 (Invitrogen). LA 
fibroblasts from control dogs were isolated and grown in T75 flasks. 
At near confluence (3–4 days of culture), fibroblasts were trypsin-
ized, counted, and plated in 12-well plates at 4.4×104 cells per well. 
After 4 to 6 hours of recovery, cells were exposed to AMO-26a, 
AMO-NC, or vehicle in Lipofectamine. After overnight incubation, 
cells were washed 3× with 10% fetal bovine serum medium. After 
an additional 48 hours of transfection, cells were used for patch-
clamp studies.
Taqman Real-Time Quantitative Reverse 
Transcription Polymerase Chain Reaction
Freshly isolated dog fibroblasts were resuspended in a lysis buf-
fer, and RNA was isolated with Nucleospin RNA II (Macherey 
Nagel), including DNase treatment to prevent genomic con-
tamination. Messenger RNAs were reverse-transcribed with the 
High-Capacity Reverse Transcription Kit (Applied Biosystems). 
Quantitative polymerase chain reaction was performed with TaqMan 
probes and primers from Applied Biosystems for housekeeping 
genes HPRT, β2-microglobulin, and G6PD, as well as for KCNJ2, 
collagen-1, collagen-3, fibronectin-1, fibrillin-1, and α-smooth 
muscle actin (α-SMA). SyBr green primers were used to quantify 
KCNJ12 and KCNJ4. The geometric mean expression of HPRT, β2-
microglobulin, and G6PD was used for normalization. Quantitative 
polymerase chain reaction reactions were performed with Taqman 
Gene Expression Master Mix (Applied Biosystems). Reactions were 
run on a Stratagene MX3000. Relative gene expression values were 
calculated by the 2−ΔCt method.
Immunostaining
Freshly isolated and cultured fibroblasts were rinsed with PBS 
and fixed for 10 minutes with 1:1 acetone:methanol at −20°C, and 
then cells were blocked for 1 hour with 5% bovine serum albumin 
at room temperature. The fibroblasts were incubated with mouse 
anti-α-SMA (1/500; Sigma), goat antivimentin (1/500; Santa 
Cruz), followed by donkey antimouse IgG-Alexa Fluor 555 (1/500; 
Invitrogen), donkey anti-rabbit IgG-Alexa Fluor 488 (1/500; 
Invitrogen), and TOPRO-3 iodide (1/1000; Invitrogen). Fluorescent 
images were obtained with an Olympus Fluoview FV1000 inverted 
confocal microscope.
Western Blots
Protein was extracted, quantified, and processed as we previously de-
scribed.8 Freshly isolated fibroblasts were lysed in detergent-based 
buffer (150 mmol/L NaCl, 20 mmol/L Tris–HCl, pH 7.4, 1 mmol/L 
EDTA, 1 mmol/L EGTA, 1% Nonidet P-40, 1% Triton X-100, 1 
mmol/L NaF, 1 mmol/L Na3VO4, and protease inhibitors). Protein 
samples were separated by gel electrophoresis and transferred to 
polyvinylidene difluoride membranes. Membranes were blocked 
and incubated with mouse anti-α-SMA (1/1000; Sigma), goat an-
tivimentin (1/1000; Santa Cruz), anti-Kir2.1 (1:200; Neuromab), 
and GAPDH (1/10 000; Fitzgerald) antibodies. Secondary antibod-
ies conjugated to horseradish peroxidase were used for detection via 
chemiluminescence.
Data Analysis
Clampfit 9.2 (Axon), GraphPad Prism 4.0, and Origin 5.0 were used 
for data analysis. All data are expressed as mean±SEM. Multiple 
group statistical comparisons were obtained by 2-way ANOVA, and 
individual group mean differences were evaluated by Student t tests 
with Bonferroni correction. A 2-tailed P<0.05 was considered statis-
tically significant.
Results
Properties of the Model
CHF significantly increased right-atrial effective refractory 
period at all basic cycle lengths (Online Figure IA). Mean AF 
duration increased substantially in dogs with CHF (Online 
Figure IB). CHF reduced arterial pressures and increased fill-
ing pressures (Online Figure IC–IE). Atrial histopathology 
confirmed the presence of fibrosis in dogs with CHF (Online 
Figure II), and quantitative polymerase chain reaction con-
firmed enhanced extracellular matrix gene expression (Online 
Figure IIIA and IIIB).
CHF-Induced Changes in Fibroblast Phenotype
Bright field microscopic images of freshly isolated fibro-
blasts from each group are shown in Figure 1A, with CHF 
fibroblasts being systematically larger (Figure 1B–1D). 
Immunoflorescence suggested that CHF fibroblasts exhibited 
enhanced vimentin and α-SMA expression (Figure 1E), an im-
pression confirmed by image quantification (Figure 1F and 1G). 
Western blot analysis further supported CHF-induced fibroblast 
α-SMA and vimentin upregulation (Figure 1H and 1I). Gene 
expression mRNA levels corresponding to  the extracellular 
matrix proteins collagen-1, collagen-3, fibronectin-1, and fibril-
lin-1 were all greater in freshly isolated CHF fibroblasts versus 
control fibroblasts (Online Figure IIIA and IIIB). These obser-
vations indicate that CHF alters atrial fibroblast phenotype.
Changes in IK1 and RMP
Figure 2A and 2B show examples of IK1 recordings from 
freshly isolated fibroblasts obtained with the ramp protocol 
shown in the inset. The current was strongly suppressed by 
300 μmol/L Ba2+. Overall data (Figure 2C) indicate signifi-
cantly larger IK1 in CHF. CHF significantly increased the ex-
pression of KCNJ2 (Kir2.1) at both mRNA (by 52%) and 
protein (by 80%) levels (Figure 2D and 2E). KCNJ12 (Kir2.2) 
mRNA expression (Online Figure IIIC) was 2 orders of mag-
nitude less than that of KCNJ2 (Online Figure IIID) and was 
not affected by CHF. KCNJ4 (Kir2.3) was undetectable. CHF 
significantly increased RMP (from −43.2±0.8 mV, control, to 
−55.5±0.9 mV; P<0.001; Figure 2F). Ba2+ (300 μmol/L) sig-
nificantly reduced RMP and greatly attenuated the RMP dif-
ferences between control and CHF fibroblasts, suggesting that 
they were due to IK1 upregulation in CHF (Figure 2F). Similar 
effects were seen with a 10-fold larger Ba2+ concentration (3 
mmol/L; Figure 2G). Of note, despite the statistically signifi-
cant reduction in RMP with Ba2+, the fibroblasts maintained 
a negative RMP, indicating a contribution from conductances 
other than IK1.
To further verify the role of IK1 in fibroblast RMP changes 
with CHF, we performed the studies shown in Online Figure 
IV. Consistent with expected behavior, the current conductance 
(and particularly the inward current component) was greatly 
enhanced (Online Figure IVA and IVB) by increasing extracel-
lular K+ concentration ([K+]
o
) to 75 mmol/L (equimolar substi-
tution for Na+). In addition to enhancing conductance (Online 
Figure IVC and IVD), increased [K+]
o
 shifted the reversal 
potential positively, from −53.4±3.7 mV and −64.3.7±3.8 
mV with 5.4 mmol/L [K+]
o
 in controls and dogs with CHF, 
respectively, to −14.9±1.1 mV (P<0.001) and −15.1±1.1 mV 
 at SZTE ALTALANOS ORVOSTUDOMANYI KAR on June 11, 2016http://circres.ahajournals.org/Downloaded from 
Qi et al  Atrial Fibroblast IK1 and Remodeling in CHF  839
(P<0.001) in 75 mmol/L [K+]
o
. The RMP was significantly re-
duced by 75 mmol/L [K+]
o
 for both control and CHF conditions 
(Online Figure IVE and IVF) and elevating [K+]
o
 largely elimi-
nated the RMP differences between controls and dogs with 
CHF, with values averaging −30.9±1.5 mV and −32.5±1.6 mV, 
respectively, in 75 mmol/L [K+]
o
 (P=not significant).
Changes in Fibroblast Ca2+ Entry
Figure 3A and 3B show store-dependent Ca2+ entry data from 
control and CHF fibroblasts, respectively. Cells in short-term 
(20 hours) culture were first exposed to nominally Ca2+-
free extracellular solution to deplete Ca2+ stores, and then 
Ca2+ entry was observed on increasing [Ca2+]
o
 to 10 mmol/L 
Figure 2. A and B, IK1 recordings (at 0.1 
Hz) from control (CTL) and congestive 
heart failure (CHF) freshly isolated atrial 
fibroblasts. C, Mean±SEM current density 
vs voltage relationships for Ba2+ sensitive 
IK1 in freshly isolated atrial fibroblasts.  
D, Mean±SEM KCNJ2 mRNA expression. 
E, Mean±SEM Kir2.1 protein expression. 
F and G, Mean±SEM resting membrane 
potential (RMP) before and after 300 
μmol/L or 3 mmol/L Ba2+. *P<0.05, 
**P<0.01, and ***P<0.001 CTL vs CHF; 
###P<0.001 pre-Ba2+ vs post-Ba2+; n/
N=cells/dogs per group. TP indicates test 
potential.
Figure 1. A, Microscopic images of freshly isolated fibroblasts from control (CTL) and congestive heart failure (CHF) canine left atria. 
B–D, Mean±SEM cell diameter, cell area, and cell membrane capacitance of CTL and CHF fibroblasts. E, Immunofluorescent images of 
freshly isolated CTL and CHF fibroblasts. Staining shown is vimentin (green) and α-SMA (red). F–G, Mean±SEM α-SMA and vimentin 
immunofluorescence quantification based on images like those in E. H and I, Mean±SEM α-smooth muscle actin (α-SMA) and vimentin 
immunoblot band intensities/GAPDH band intensities. *P<0.05 and ***P<0.001 CTL vs CHF; n/N=cells/dogs per group.
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(Figure 3A and 3B). Resting [Ca2+]i (Figure 3C) and store-
dependent Ca2+ entry (Figure 3D) were greater in CHF cells. 
We were unable to use Ba2+ as a probe to inhibit IK1 and study 
the role of IK1 differences in Ca2+ entry because Ba2+ interacts 
directly with Fura-2.11 However, increasing [K+]
o
 to reduce 
RMP substantially suppressed store-dependent Ca2+ entry 
under both control and CHF conditions and greatly reduced 
the difference between control and CHF values (Figure 3D). 
These results suggest that RMP is a significant determinant 
of fibroblast Ca2+ entry and that RMP differences due to IK1 
remodeling may contribute to the increased Ca2+ entry caused 
by CHF.
Fibroblast Proliferation and Differentiation
To study CHF-induced changes in fibroblast proliferation and 
differentiation, along with the potential contribution of IK1 re-
modeling, we had to perform experiments with short-term (3 
days) cultured cells. We first verified that 3-day culture does 
not alter fibroblast IK1 or RMP (Online Figure V). We then 
collected fibroblasts for proliferation analysis by flow cytom-
etry. Figure 4A and 4B show representative DNA-content 
histograms and Dean–Jett–Fox model fitting of control and 
CHF atrial fibroblasts (G0: resting phase; G1 phase: increased 
size and ready for DNA synthesis; G2/M phase: cells with 
doubled DNA content in premitotic and mitotic phases). CHF 
increased the total cell count and cell content in the G2/M 
phase (Figure 4C and 4D). Mean total cell counts are shown 
in Figure 4C and percentages in each phase in Figure 4D. 
CHF significantly increased the percentage of cells in the 
G2/M phase (Figure 4D), indicating increased proliferation. 
Cultured CHF fibroblasts also showed properties indicating 
greater myofibroblast differentiation versus control fibro-
blasts, including altered cell morphology and greater expres-
sion of vimentin and α-SMA protein (Online Figure VI).
IK1 Regulates RMP, Ca2+ Entry, and Proliferation
The experiments shown in Figure 3 suggest that IK1 may con-
tribute to the control of atrial fibroblast Ca2+ entry. To explore 
the functional contributions of IK1 more directly, we used a 
gene transfer approach to vary the current in fibroblasts. A 
dominant negative KCNJ2 construct (KCNJ2-DN) with the 
GYG motif replaced by a triple-alanine (AAA) sequence 
Figure 3. A and B, Recordings of store-
operated Ca2+ influx in control (CTL) 
and congestive heart failure (CHF) 
freshly isolated atrial fibroblasts, in the 
presence of 5.4 mmol/L or 75 mmol/L 
[K+]o, with protocol shown at the top. C, 
Mean±SEM resting intracellular [Ca2+]. D, 
Mean±SEM store-dependent Ca2+ influx. 
*P<0.05, **P<0.01, CTL vs CHF; #P<0.05, 
5.4 mmol/L [K+]o vs 75 mmol/L [K
+]o; n/
N=cells/dogs per group.
Figure 4. A and B, Representative DNA-
content histograms and Dean–Jett–Fox 
model fitting of 3-day cultured atrial 
fibroblasts from a control (CTL) and 
a dog with congestive heart failure 
(CHF). C, Mean±SEM cell count of atrial 
fibroblasts from CTL and dogs with CHF. 
D, Mean±SEM percentage of cells in G0/
G1 and G2/M phases. *P<0.05, **P<0.01, 
and ***P<0.001 CTL vs CHF. PI indicates 
propidium iodide.
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was used to suppress endogenous KCNJ2 current. Wild-type 
KCNJ2 overexpression (KCNJ2-OE) was used to enhance the 
current. KCNJ2-DN and wild-type KCNJ2 were packed into 
a lentivirus vector containing GFP. A control virus was also 
prepared that contained only GFP inserted into the lentiviral 
vector. Infected cells were identified by green fluorescence.
Figure 5A shows original recordings of IK1 in fibroblasts in-
fected with controls (lentivirus carrying GFP alone), KCNJ2-
DN, and KCNJ2-OE constructs, before and after the addition of 
300 μmol/L of Ba2+ to the superfusate. Currents were reduced 
by KCNJ2-DN and increased by KCN2-OE and strongly sup-
pressed by Ba2+. Figure 5B shows current–voltage relation-
ships, with an inset showing control and KCNJ2-DN currents 
on an expanded current scale for clearer resolution. KCNJ2-OE 
greatly increased IK1, whereas KCNJ2-DN strongly reduced IK1 
density. Compatible with a role of IK1 in fibroblast differentia-
tion, cell capacitance increased with KCNJ2-OE (Figure 5C). 
KCNJ2-OE substantially hyperpolarized the RMP, and consis-
tent with the effects of Ba2+ shown in Figure 2F and 2G, KCNJ2-
DN significantly reduced RMP. Exposure to Ba2+ eliminated the 
RMP differences among constructs (Figure 5D and 5E) with 
full effects seen at 300 μmol/L, consistent with the notion that 
the RMP differences are caused by changes in IK1.
We then went on to use the gene transfer approach to con-
firm directly the ability of IK1 to regulate atrial fibroblast Ca2+ 
entry and proliferation. KCNJ2-DN decreased, and KCNJ2-
OE increased, the resting Ca2+ level (Figure 6A) and store-
operated Ca2+ entry (Figure 6B). Increased [K+]
o
 attenuated 
Ca2+ entry in the presence of the lentiviral-GFP control vector 
and KCNJ2-OE (Figure 6B), but as expected given the virtual 
elimination of IK1 produced by KCNJ2-DN, elevated [K+]o did 
not alter Ca2+ entry in the presence of KCNJ2-KD. Fibroblast 
proliferation indices were enhanced by KCNJ2-OE and sup-
pressed by KCNJ2-DN (Figures 6C and 6D). These results 
confirm the role of IK1 in governing fibroblast Ca2+ entry and 
proliferation.
Role of RMP in Controlling Fibroblast Ca2+ Entry
The most obvious way in which changes in IK1 could affect 
fibroblast Ca2+ entry is through resulting changes in RMP 
and the voltage gradient driving Ca2+ into the cell. To test di-
rectly the effect of RMP on fibroblast Ca2+ entry, we studied 
store-operated Ca2+ entry in fibroblasts under voltage-clamp 
conditions, with voltages set to approximate the RMP of 
control fibroblasts (−40 mV) and CHF fibroblasts (−55 mV). 
Figure 7A shows [Ca2+]i recordings in one cell, obtained at a 
holding potential of −40 mV (left) and then in the same cell 
at −55 mV (right). Hyperpolarizing the fibroblast increased 
the Ca2+-transient amplitude. Figure 7B shows the mean Ca2+-
transient amplitude in cells in which we were able to study 
Ca2+ entry under stable conditions under both voltages (order 
randomized in different cells). RMP had a highly significant 
effect on Ca2+-transient amplitude.
MicroRNA-26 Regulation of Atrial Fibroblast IK1
The larger increase in the KCNJ2 protein than mRNA in 
CHF points to mediation by microRNA. We have previously 
shown that miR-26 targets IK1 and that its downregulation 
in cardiomyocytes from animals with sustained AF governs 
cardiomyocyte IK1 enhancement.12 We therefore considered 
the possibility that miR-26 regulation may contribute to the 
atrial fibroblast IK1 enhancement that we observed in CHF. 
Expression of the miR-26a isoform was decreased in freshly 
isolated LA fibroblasts from dogs with CHF, whereas miR-26b 
Figure 5. A, Representative IK1 recordings in green fluorescent protein (GFP)–expressing control (Lenti-GFP), KCNJ2 dominant negative 
(KCNJ2-DN), and KCNJ2–overexpressing (KCNJ2-OE) fibroblasts in primary culture. B, Mean±SEM Ba2+-sensitive IK1 density–voltage 
relationships in cells infected with Lenti-GFP, KCNJ2-DN, and KCNJ2-OE vectors. Inset: Lenti-GFP and KCNJ2-DN data on enlarged 
current scale. C, Mean±SEM cell capacitance. D and E, Mean±SEM resting membrane potential (RMP) before and after 300 μmol/L and 
3 mmol/L Ba2+. **P<0.01 and ***P<0.001 control vs Lenti-GFP. #P<0.05 and ###P<0.001 pre-Ba2+ vs post-Ba2+; n/N=cells/dogs per group. 
TP indicates test potential; and WT, wild-type.
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was unaffected (Figure 8A). AMO-26a transfection into atrial 
fibroblasts with lipofectamine effectively suppressed miR-26a 
(Figure 8B, left). To exclude nonspecific effects, we exam-
ined miR-21 expression, which was unaffected by AMO-26a 
(Figure 8B, right). We then looked at the result of knocking 
down miR-26a, to mimic its downregulation in CHF, on IK1 in 
atrial fibroblasts. Figure 8C shows original recordings from a 
fibroblast exposed to lipofectamine alone, a fibroblast exposed 
to a scrambled-control oligonucleotide (AMO-NC), and a fi-
broblast transfected with AMO-26a. IK1 was clearly larger 
after AMO-26a exposure, as indicated by the mean current–
voltage data in Figure 8D. Finally, we examined the effect of 
miR-26a knockdown on atrial fibroblast RMP and noted sub-
stantial hyperpolarization (Figure 8E).
Discussion
In this study, we analyzed the consequences of CHF-induced 
IK1 upregulation in fibroblasts on fibroblast function, noting 
hyperpolarized RMP, enhanced Ca2+ entry, and increased pro-
liferation indices. The mechanistic role of IK1 changes was 
supported by genetically modifying IK1 through KCNJ2-OE 
and knockdown, and the potential contribution of hyperpo-
larization to CHF-induced fibroblast Ca2+ entry increases was 
demonstrated by simultaneous voltage clamp and Ca2+ micro-
fluorometry. CHF-induced miR-26a downregulation was im-
plicated as the mechanism of KCNJ2/ IK1 upregulation.
Functional Role of Ion Channels in Cardiac 
Fibroblasts
Although the presence of ion channels in cardiac fibroblasts 
is well established,3 their functional role is less clear. Ca2+ en-
try via nonselective cation channels of the transient receptor 
potential family plays a role in fibroblast proliferation, differ-
entiation, and extracellular matrix protein secretion.8,13 There 
is evidence that this action is mediated via Ca2+-dependent 
activation of extracellular signal–related protein kinases14 and 
contributes to the AF-related arrhythmogenic substrate.8,13 The 
function of fibroblast K+ channels is less clear. Previous work 
has indicated that Kir channels contribute to RMP determina-
tion. In cell coculture systems, myofibroblasts can be shown 
to couple to cardiomyocytes and alter their electrophysi-
ological properties, inducing a variety of arrhythmogenic 
mechanisms.14,15 Although the importance of fibroblast–car-
diomyocyte coupling in vivo is still controversial, mathemati-
cal modeling work suggests that it may account for complex 
fractionated electrogram properties in fibrotic tissues.16 We 
have recently evaluated the effects of fibroblast ion channel 
remodeling on the potential electric and arrhythmogenic inter-
actions between coupled fibroblasts and cardiomyocytes, find-
ing that if fibroblasts were well coupled to cardiomyocytes, 
fibroblast Kv current downregulation would suppress the AF-
substrate, whereas Kir current upregulation would enhance 
Figure 6. A, Mean±SEM resting 
intracellular [Ca2+] in green fluorescent 
protein (GFP)–expressing control 
(Lenti-GFP), KCNJ2 dominant negative 
(KCNJ2-DN), and KCNJ2–overexpressing 
(KCNJ2-OE) fibroblasts. B, Mean±SEM 
Ca2+ influx (ΔCa2+ratio) at 5.4 and 75 
mmol/L [K+]o. C, Mean±SEM cell count of 
atrial fibroblasts in various phases from 
Lenti-GFP, KCNJ2-DN, and KCNJ2-OE 
groups. D, Mean±SEM percentage of 
cells in G0/G1 and G2/M phases. *P<0.05 
and ***P<0.001 vs Lenti-GFP; #P<0.05 
and ###P<0.001, 5.4 vs 75 mmol/L [K+]o; n/
N=cells/dogs per group.
Figure 7. A, Original recordings of intracellular [Ca2+] in one fibroblast held at −40 mV (left) and −55 mV (right) to mimic resting membrane 
potential in control and congestive heart failure fibroblasts. B, Mean±SEM Ca2+ influx (ΔCa2+ratio) in 24 cells held at both −40 and −55 mV.
 at SZTE ALTALANOS ORVOSTUDOMANYI KAR on June 11, 2016http://circres.ahajournals.org/Downloaded from 
Qi et al  Atrial Fibroblast IK1 and Remodeling in CHF  843
it.17 We have also obtained evidence for a profibrotic role of 
Kv current downregulation, although the underlying mecha-
nism is unclear.6
Control of Fibroblast Ca2+ Entry and Function by 
Kir Currents
This study is the first of which we are aware to show the con-
trol of fibroblast Ca2+ entry and proliferation by Kir2.1 cur-
rent. Several lines of evidence converged to clarify the role of 
fibroblast IK1. IK1 block with Ba2+ or K+ driving force reduction 
by elevating [K+]
o
 reduced the RMP and elevated [K+]
o
 re-
duced fibroblast store-operated Ca2+ entry. Functional KCNJ2 
knockdown with dominant negative overexpression reduced 
atrial fibroblast IK1, RMP, Ca2+ influx, and proliferative activ-
ity, whereas KCNJ2-OE had the opposite effects. The role 
of RMP in mediating IK1 effects on Ca2+ entry was directly 
supported by experiments showing that hyperpolarization of 
voltage-clamped fibroblasts enhanced fibroblast store-operat-
ed Ca2+ entry.
Although this functional role has never before been de-
scribed in fibroblasts, there is supportive evidence from previ-
ous work in endothelial cells. Bradykinin-induced changes in 
bovine endothelial cell cytosolic Ca2+ are consistent with an 
influx mechanism directly related to the Ca2+ electrochemical 
gradient.18 Nitric oxide synthesis and proliferation of umbili-
cal cord endothelial cells induced by basic fibroblast growth 
factor seem to depend on inward-rectifier K+ current aug-
mentation.19 Finally, hyperpolarization increases cytoplasmic 
[Ca2+] in arteriolar endothelial cells.20
Novel Elements and Potential Significance
Cardiac fibrosis is an important contributor to cardiac dys-
function and arrhythmogenesis, and it is a particularly sig-
nificant contributor to the substrate that allows enhanced AF 
maintenance in CHF.21 Fibroblasts play a central role in the 
fibrotic process.22 Here, we addressed a novel regulatory as-
pect of fibroblast physiology, functional control by IK1, along 
with the remodeling of IK1 and its contribution to altered fi-
broblast function in a clinically relevant fibrotic paradigm: 
the CHF-induced atrial profibrillatory substrate.1,2 We report 
for the first time that CHF-related atrial IK1 upregulation and 
consequent fibroblast hyperpolarization enhance fibroblast 
Ca2+ entry and cell proliferation. This work identifies a novel 
participant in the profibrotic response, with potential implica-
tions for the development of novel therapeutic interventions. 
Ion channels are targets for new antiarrhythmic agents.23 
Our study shows that in addition to altering cardiac electro-
physiology, interventions that target IK1 may affect cardiac 
structural remodeling, particularly because the principal IK1 
subunit, KCNJ2/Kir2.1, is common to both cardiomyocytes 
and fibroblasts. The predominance of KCNJ2 in cardiac IK1 is 
well recognized.24 This study indicates that KCNJ2 is similar-
ly predominant in fibroblasts: DN-KCNJ2 almost completely 
eliminated fibroblast IK1 (Figure 5B, inset). IK1 blockers are 
being developed as potential antiarrhythmic molecules,25,26 
based on their ability to inhibit cardiomyocyte IK1 and de-
stabilize AF-maintaining rotors.26,27 An additional potentially 
interesting consequence, based on the work reported here, 
might be the suppression of atrial fibrosis. The converse 
may also hold. Fibroblasts engineered to overexpress Kir2.1, 
Nav1.5, and connexin-43 subunits rescue normal propagation 
and decrease arrhythmia complexity in cocultured cardio-
myocyte–fibroblast monolayers.28 A risk of applying this ap-
proach therapeutically might be the profibrotic consequences 
of increased IK1.
MicroRNAs are significant control molecules in cardiac 
remodeling.29 We have previously shown that miR-26 down-
regulation contributes to AF-promoting remodeling by up-
regulating cardiomyocyte IK1.12 Here, we have identified an 
additional potential profibrillatory consequence of disease-
related miR-26 downregulation: fibroblast activation via fi-
broblast IK1 upregulation consequent to removal of miR-26 
induced negative regulation of the KCNJ2 gene.
Figure 8. A, Mean±SEM relative microRNA 
expression in freshly isolated left atrial fibroblasts. 
B, Efficiency of miR-26a knockdown by anti-miR-
26a oligonucleotide (AMO-26a) in canine left atrial 
fibroblasts. miR-21 was unaffected by AMO-26a. 
C, IK1 recordings (voltage-ramp protocol in the 
inset delivered at 0.1 Hz). D, Mean±SEM 300 
μmol/L Ba2+–sensitive IK1 density. E, Mean±SEM 
resting membrane potential (RMP). **P<0.01 
and ***P<0.001 Lipo vs AMO-26a; n/N=cells/
dogs per group. AMO-NC indicates scrambled 
oligonucleotides with methylene bridges used as 
negative control for AMO-26a; CHF, congestive 
heart failure; CTL, control; and Lipo, lipofectamine 
control.
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Potential Limitations
Fibroblast hyperpolarization significantly increased store-
operated Ca2+ entry by ≈30% (Figure 7B); however, CHF fi-
broblasts showed an ≈70% increase in Ca2+ entry (Figure 3D). 
Thus, the hyperpolarization caused by IK1 upregulation is like-
ly not the only factor increasing Ca2+ entry in CHF fibroblasts. 
In addition to KCNJ2, miR-26 controls the expression of the 
gene encoding TRPC3 subunits.8 TRPC3 subunit upregula-
tion caused by miR-26 downregulation in AF enhances fibro-
blast Ca2+ entry.8 Thus, TRPC3 expression changes caused by 
CHF-induced miR-26a downregulation likely also contributed 
to the increased fibroblast Ca2+ entry observed in CHF fibro-
blasts in this study.
We performed experiments in isolated fibroblasts to evalu-
ate their cell biology in detail. Analysis of fibroblast properties 
in situ is greatly complicated by their small size and a dearth 
of specific probes. Paracrine effects in vivo could significantly 
alter fibroblast behavior and were not analyzed here. In addi-
tion, in this study we measured the fibrous-tissue content only 
in the LA appendage (Online Figure II). The distribution of 
fibrosis may not be uniform in atria.
Fibroblast proliferation might be affected by lentiviral in-
fection. We therefore verified cell counts on culture in con-
trol fibroblasts versus lentivirus-GFP infected fibroblasts and 
found no significant differences (Online Figure VII).
We used Ba2+ as one of several tools to compare the con-
tribution of IK1 in CHF fibroblasts with that in control. Ba2+ 
can affect a variety of K+ currents, and the possibility of non-
specific effects requires caution in the interpretation of data. 
Evidence against any significant nonspecific effects of Ba2+ in 
our system is provided by the results of KCNJ2 knockdown on 
the response to Ba2+ (Online Figure VIII). Ba2+ had no signifi-
cant effect on currents once KCNJ2/ IK1 was knocked down, 
indicating the absence of any significant effect on other cur-
rents under our recording conditions.
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What Is Known?
•	 Cardiac fibroblasts play a central role in tissue fibrosis, which are an im-
portant contributor to a variety of arrhythmias, including atrial fibrillation.
•	 Cardiac fibroblasts possess a range of ion channels, but the functional 
role of fibroblast ion channels is poorly understood.
•	 Congestive heart failure (CHF) causes prominent atrial fibrosis, and is, 
therefore, a major risk factor for the arrhythmia.
What New Information Does This Article Contribute?
•	 CHF leads to the upregulation of the background inward-rectifier po-
tassium current (I
K1
) in atrial fibroblasts, likely by downregulating a 
microRNA (miR-26) that targets I
K1
.
•	 An increase in atrial fibroblast I
K1
 hyperpolarizes the cell membrane, 
enhancing Ca2+ entry by increasing the driving force for transmem-
brane Ca2+ movement.
•	 These findings define a new pathway for CHF-induced atrial fibrosis 
involving an increase in I
K1
, leading to hyperpolarization and enhanced 
Ca2+ entry and resulting in fibroblast activation.
CHF is an important clinical risk factor for atrial fibrillation, 
the commonest sustained arrhythmia and a major source of 
morbidity and mortality. Although CHF-induced atrial fibrosis 
is thought to contribute to the atrial fibrillation substrate, the 
mechanisms leading to this fibrosis are poorly understood. 
Moreover, the functional roles of ion channels in fibroblasts, the 
cells that produce fibrosis, are not well understood. Here, we 
studied changes in the background inward-rectifier potassium 
current (I
K1
) in atrial fibroblasts from dogs with CHF induced by 
ventricular tachypacing. We found significant upregulation of 
I
K1
, which hyperpolarized the resting membrane potential of the 
fibroblasts. This hyperpolarization enhanced Ca2+ entry, known 
to be an important fibroblast-activating mechanism, causing 
fibroblasts to proliferate. We also found that I
K1
 upregulation is 
caused by CHF-induced decreases in atrial fibroblast expression 
of a microRNA, miR-26, that targets the gene (KCNJ2) encoding 
I
K1
. These findings reveal a new function of fibroblast potassium 
channels, ie, the control of fibroblast activation, and show that 
these channels can mediate a pathological arrhythmia–pro-
moting response. Further elucidation of this signaling pathway 
would provide novel insights into the mechanisms controlling 
atrial fibrillation and might allow for the development of new 
therapeutic approaches.
Novelty and Significance
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Supplemental Figures 
 
  
 
Supplemental Figure I. A, Mean±SEM atrial effective refractory period (ERP) as a function of basic cycle length (BCL).  B, 
Mean±SEM duration of induced atrial fibrillation (AF) in control (CTL) and CHF. C, Mean±SEM blood pressure (BP). D, 
Mean±SEM left ventricular systolic pressure (LVSP) and left ventricular end diastolic pressure (LVEDP). E, Mean±SEM left atrial 
pressure (LAP) and right atrial pressure (RAP). *P<0.05, **P<0.01, ***P<0.001 vs CTL.  
 
 
Supplemental Figure II. A-B, Masson's trichrome-stained light micrographs from a CTL (A) and a CHF (B) dog left atrial appendage 
(×200 magnification). C, Mean±SEM fibrosis tissue content (percentage of cross-sectional area) in left atrial appendage ***P<0.001 
vs CTL.  
 
 
Supplemental Figure III. A-B, Mean±SEM extracellular matrix gene mRNA-expression in freshly-isolated atrial fibroblasts from CTL 
and CHF dogs. C, Mean±SEM KCNJ12 (Kir2.2) mRNA expression level. D, Mean±SEM KCNJ2 (Kir2.1) mRNA expression level. 
*P<0.05, **P<0.01, ***P<0.001 CTL vs CHF. 
 
  
 
Supplemental Figure IV.  A- B. Inwardly-rectifying K+-current inward components are enhanced by 75 mol/L K+o (reversal potential 
also shifted in the positive direction) and currents are blocked by 300 µmol/L Ba
2+ 
in freshly-isolated CTL and CHF atrial fibroblasts. 
C-D, Mean±SEM inwardly rectifying K+ current-density. E-F, Mean±SEM RMP in CTL and CHF freshly-isolated atrial fibroblasts 
before and after 75 mmol/L [K
+ 
]o-exposure. *,**, ***: P<0.05, 0.01, 0.001 for 5.4 mmol/L K
+
 vs 75 mmol/L K
+
, n/N=cells/dogs per 
group.  
 
 
Supplemental Figure V. A, Mean±SEM current-voltage relations of Ba2+-sensitive current from freshly-isolated and 3-day cultured 
atrial fibroblasts. B, Mean±SEM RMP from freshly-isolated and 3-day cultured atrial fibroblasts. 
 
  
 
 
Supplemental Figure VI. A, Immunofluorescent images of 3-day cultured control (CTL) dog atrial fibroblasts. B, Immunofluorescent 
images of 3-day cultured CHF dog atrial fibroblasts. Staining shown is vimentin (green), α-SMA (red), TOPRO3 (blue, nuclear) and 
merged. 
  
 
 
Supplemental Figure VII. Comparison of fibroblast proliferation in A, Control (CTL) fibroblasts and B, Lenti-GFP infected fibroblasts. 
Bright-field images are at left; fluorescent images are at the right. Cell counts after 3 days in culture were 58.2 ± 4.5/high-power field 
(HPF) for CTL versus 57.0 ± 3.2/HPF for Lenti-GFP (N=5, 6 respectively). To obtain cell counts, cells were cultured in the same 
general way as for flow cytometry, but rather than being passed through a flow cytometer, cells were counted visually under 
microscopy with a 40× objective lens. 
  
 
 
Supplemental Figure VIII. Currents measured in cells infected with KCNJ2-DN bearing lentivirus, before and after exposure to 300 
µmol/L Ba
2+
. Ba
2+
 had no statistically significant effect on these currents (2-way ANOVA, Ba
2+
 effect F=0.27, P=0.606). 
 
